Current Report
Filed: 2026-02-12
Key Insights
- Artivion reported its Q4 2025 financial results, showing revenue growth of 8% year-over-year and a 120 basis point improvement in gross margins.
- The company provided guidance for fiscal year 2026, forecasting revenue growth of 10-12% and continued margin expansion.
- Artivion announced the appointment of a new Chief Commercial Officer with extensive experience in the medical device industry, signaling its focus on commercial execution.